US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 19:38:54 Source：Planet Perspective news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Student fatally shot, suspect detained at Georgia's Kennesaw State University
- Next：Ben Whishaw lights up the Croisette as he joins his co
Related articles
- Lynn Williams breaks NWSL goal
- Eased processes aid tourism growth
- Quan, Wang add two golds for China at diving World Cup
- Impeachment articles against Mayorkas to be sent to Senate
- Elon Musk gets approval from FDA to implant his Neuralink brain chip into a second patient
- Teixeira brace sees Shanghai go top in CSL
- Messi sidelined for Argentina friendlies with injury
- Liu refreshes men's 102kg world records at IWF World Cup
- Dodgers acquire pitcher Yohan Ramírez from Mets for cash
- Nations rolling out red carpet for Chinese tourists
- California congressman urges closer consultation with tribes on offshore wind
- Shanghai Disney Resort launches Earth Month activities
- Kate Martin attends WNBA draft to support Caitlin Clark, gets drafted by Las Vegas in second round
- New monster movie eyes even bigger China haul via holiday boost
- French sports minister calls for sanctions after Monaco player tapes over anti
- He's 31 points helps Shenzhen beat Tianjin in CBA
- Nanjing lose to Liaoning, miss CBA playoffs
- China unveil 31
- The unstoppable duo of Emma Stone and Yorgos Lanthimos
- Sonny Gray pitches Cardinals past his former A's as St. Louis wins 3
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Planet Perspective news portal sitemap